Gland Pharma gets EIR from USFDA for Visakhapatnam facility

24 Jun 2025 Evaluate

Gland Pharma has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) indicating closure of Pre-approval inspection (PAI) for Sterile APIs at JNPC, Visakhapatnam facility. The said inspection was conducted between February 19, 2025 and February 25, 2025. 

Gland Pharma develops, manufactures and markets complex injectables. The company sells its products primarily under a business-to-business model in many countries.

Gland Pharma Share Price

1750.55 19.70 (1.14%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×